Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment

NCT01257477 is registered in ClinicalTrials.gov with Prometheus Laboratories as lead sponsor.

NCT NCT01257477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01257477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Lead sponsor
Prometheus Laboratories
Phase
Observational
Overall status
Completed
Start date
November 30, 2010
Completion date
March 31, 2013
Enrollment
400 (estimated)
Sites
67

Conditions

As the registry lists them; a condition with its own page is linked.

irritable bowel syndrome